Abbott Laboratories shares jump as stock buying pressure builds

Traders Union
All News
Financial News
Abbott laboratories rises 3.56% today

Highlights

Abbott Laboratories shows short-term bullish momentum after a 3.56% intraday gain, but remains under medium- and long-term technical pressure.
Technical indicators are mixed, with intraday overbought signals and a prevailing bearish bias on weekly trends.
Price is expected to move between $87.34 and $91.92 in the next five sessions; a downside break signals renewed weakness.

Anton Kharitonov, expert at Traders Union, notes Abbott Laboratories has shown a short-term bullish move but remains in a persistent downtrend. He highlights the lack of supporting news and persistent negative technical signals on larger timeframes. Most momentum and trend indicators still point to bearish conditions, with only isolated intraday strength. Kharitonov stresses that resistance remains firm near $93.09 and broad downside risks are intact. "Today's bounce is not convincing — without sustained news catalysts or stronger technical reversals, downside scenarios must be respected."

Viktoras Karapetjanc, expert at Traders Union, sees the latest price action as a sign of renewal in buyer interest. He believes the short-term break above the 20-day average signals fresh opportunities. Although medium-term resistance still challenges further growth, the bullish structure remains intact if support holds above $87.34. He confidently states, "Further recovery is well within reach as long as buyers defend key short-term levels — the market offers multiple upward setups here."

Momentum conflict as intraday rally meets entrenched bearish trend

Abbott Laboratories is trading above the 20-day moving average ($86.20), below the 50-day ($93.09), and well under the 200-day ($115.95), suggesting short-term bullish momentum but ongoing medium- and long-term pressure from sellers. The nearest dynamic support is at the Ichimoku Kijun ($88.38), with resistance coming in at the 50-day moving average around $93.09. Momentum signals are mixed. The Moving Average Convergence Divergence (MACD) and Average Directional Index (ADX) reflect a strong bearish bias and persistent negative trend despite today's upswing. Relative Strength Index (RSI) points to potential exhaustion at 44.05, while Stochastic RSI and Bull/Bear Power (BBP at 1.07) both indicate overbought conditions and buyer dominance intraday. The Commodity Channel Index (CCI) gives a moderate buy reading and the Awesome Oscillator is neutral, failing to confirm the rally. Today, the stock is up 3.10 or 3.56% after an upside gap near $3.01, but its price remains in the lower part of the session’s range with intraday volatility standing at 2.04%. The overall tone shows strength after the open, with short-term bullish action conflicting with persistent downside momentum on higher timeframes.

Earlier, analysts noted that Abbott Laboratories was exhibiting persistent bearish momentum and ongoing technical pressures despite some fundamental strengths. While today’s strong rebound demonstrates short-term bullish potential, traders should monitor whether this momentum is sustained above $91.92, as a failure to do so could quickly reignite the prevailing downside risk.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.